ACTIVE

WD-FARMA

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result62,4 k €-10,4 %over 1 year

Gross margin179,1 k €-5,6 %over 1 year

Equity479,4 k €+0,9 %over 1 year

Workforce1,9 ETP+11,8 %over 1 year

Identity

Source · BCE/KBO

WD-FARMA is a Private limited company incorporated in 2004. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Antwerpen. It employs on average 1,9 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0863.630.293
Incorporation: 24/02/2004
Legal form: Private limited company
Registered office: Boomsesteenweg 406
2020 Antwerpen · FlandreSee on map
Contributed capital: 250 704,00 €
Latest accounts: 31/12/2025
Average workforce: 1,9 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 17 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	179,1 k €	-5.6%	189,8 k €	+31.8%	143,9 k €	+9.6%	131,3 k €	-4.6%	137,6 k €
EBITDA	83,3 k €	-10.1%	92,7 k €	+110%	44,2 k €	+149%	17,8 k €	-65.1%	51 k €
Operating result	58 k €	-12.4%	66,2 k €	+100.0%	33,1 k €	+165%	12,5 k €	-63.4%	34,2 k €
Net result	62,4 k €	-10.4%	69,7 k €	+91.5%	36,4 k €	+79.4%	20,3 k €	-47.6%	38,7 k €
Balance sheet
Equity	479,4 k €	+0.9%	475,3 k €	+0.8%	471,4 k €	+2.1%	461,7 k €	+0.7%	458,5 k €
Total assets	787,9 k €	-5.0%	829,4 k €	+8.3%	765,7 k €	+33.5%	573,5 k €	-4.1%	597,8 k €
Cash	151,3 k €	+12.3%	134,7 k €	+18.7%	113,5 k €	+7.7%	105,4 k €	+4.9%	100,5 k €
Debts	308,5 k €	-12.9%	354 k €	+20.4%	294 k €	+165%	110,8 k €	-20.1%	138,6 k €
Other
Workforce	1,9 ETP	+11.8%	1,7 ETP	-5.6%	1,8 ETP	-14.3%	2,1 ETP	+10.5%	1,9 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 5 ended

Active mandates

KREAFARMA

Director · since 25 juillet 2018 · 0684.714.981

Represented by Wymeersch Annabel

Active

Ended mandates

KREAFARMA

Director · since 25 juillet 2018 · 0684.714.981

Represented by De Heyn Thierry

Ended

KREAFARMA

Director · 0684.714.981

Represented by Annabel WYMEERSCH

Ended

KREAFARMA

Director · 0684.714.981

Represented by Annabel WYMEERSCH

Ended

RITA HEREMANS

Manager

Ended

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	14/07/2026	16/07/2025	27/06/2024	20/06/2023	30/06/2022	23/06/2021
General meeting	15/06/2026	15/06/2025	15/06/2024	15/06/2023	15/06/2022	15/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	15/06/2026	14/07/2026	Dutch	PDF
Abridged model	31/12/2024	15/06/2025	16/07/2025	Dutch	PDF
Abridged model	31/12/2023	15/06/2024	27/06/2024	Dutch	PDF
Abridged model	31/12/2022	15/06/2023	20/06/2023	Dutch	PDF
Abridged model	31/12/2021	15/06/2022	30/06/2022	Dutch	PDF
Abridged model	31/12/2020	15/06/2021	23/06/2021	Dutch	PDF
Abridged model	31/12/2019	15/06/2020	31/08/2020	Dutch	PDF
Abridged model	31/12/2018	15/06/2019	30/08/2019	Dutch	PDF
Abridged model	31/12/2017	15/05/2018	11/06/2018	Dutch	PDF
Abridged model	31/12/2016	30/06/2017	26/07/2017	Dutch	PDF
Abridged model	31/12/2015	06/06/2016	22/06/2016	Dutch	PDF
Abridged model	31/12/2014	05/06/2015	02/07/2015	Dutch	PDF
Abridged model	31/12/2013	15/05/2014	13/06/2014	Dutch	PDF
Abridged model	31/12/2012	15/05/2013	27/05/2013	Dutch	PDF
Abridged model	31/12/2011	15/05/2012	04/06/2012	Dutch	PDF
Abridged model	31/12/2010	16/05/2011	06/06/2011	Dutch	PDF
Abridged model	31/12/2009	05/06/2010	02/07/2010	Dutch	PDF
Abridged model	31/12/2008	15/05/2009	12/06/2009	Dutch	PDF
Abridged model	31/12/2007	15/05/2008	12/06/2008	Dutch	PDF
Abridged model	31/12/2006	15/05/2007	14/06/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 5 ended

Active mandates

KREAFARMA

Director · since 25 juillet 2018 · 0684.714.981

Represented by Wymeersch Annabel

Active

Ended mandates

KREAFARMA

Director · since 25 juillet 2018 · 0684.714.981

Represented by De Heyn Thierry

Ended

KREAFARMA

Director · 0684.714.981

Represented by Annabel WYMEERSCH

Ended

KREAFARMA

Director · 0684.714.981

Represented by Annabel WYMEERSCH

Ended

RITA HEREMANS

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates08/09/2022
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Mandates03/06/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates29/11/2018
ONTSLAGEN - BENOEMINGEN
PDF
Restructuring28/08/2018
BENAMING - KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Restructuring14/06/2018
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Capital / shares19/12/2013
KAPITAAL - AANDELEN
PDF
Other16/10/2006
DIVERSEN
PDF
Capital / shares02/08/2006
KAPITAAL - AANDELEN - ALGEMENE VERGADERING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 202562,4 k €↓
2024
Annual accounts 202469,7 k €↑
2023
Annual accounts 202336,4 k €↑
2022
Annual accounts 202220,3 k €↓
2021
Annual accounts 202138,7 k €↑
2019
Name changeWD-FARMA
2017
Annual accounts 2017-16,6 k €↓
2016
Annual accounts 201636,7 k €↑
2015
Annual accounts 201510,8 k €↓
2014
Annual accounts 201417,2 k €↓
2013
Annual accounts 201350,9 k €↑
2012
Annual accounts 201240,7 k €↓
2011
Annual accounts 201143,2 k €↓
2010
Annual accounts 201052,7 k €↑
2009
Annual accounts 200914,5 k €↓
2008
Annual accounts 200823,1 k €↓
2007
Annual accounts 200731,2 k €↑
2006
Annual accounts 20066,2 k €
2006
Name changeAPOTHEEK DE HEYN
24/02/2004
IncorporationPrivate limited company

WD-FARMA

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline